Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01788488 · ClinicalTrials.gov registry record · NA
Procalcitonin Use in Pneumonia Patients in the Critical Care Setting
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT01788488: Completed NA study, sponsored by Mayo Clinic.
NCT01788488 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01788488, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.
Interventions
- OTHER Use of procalcitonin as biomarker to guide therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01788488
The ClinicalTrials.gov registry entry for NCT01788488 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of procalcitonin as biomarker to guide therapy is the first listed.
NCT01788488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01788488 about?
NCT01788488 is a clinical study titled "Procalcitonin Use in Pneumonia Patients in the Critical Care Setting". The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.
What is the current status of trial NCT01788488?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2013-02. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01788488?
The interventions under investigation include: Use of procalcitonin as biomarker to guide therapy (OTHER).
Who is sponsoring clinical trial NCT01788488?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.